Cargando…
A Perspective on Therapeutic Pan-Resistance in Metastatic Cancer
Metastatic spread represents the leading cause of disease-related mortality among cancer patients. Many cancer patients suffer from metastatic relapse years or even decades after radical surgery for the primary tumor. This clinical phenomenon is explained by the early dissemination of cancer cells f...
Autores principales: | Korentzelos, Dimitrios, Clark, Amanda M., Wells, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582598/ https://www.ncbi.nlm.nih.gov/pubmed/33022920 http://dx.doi.org/10.3390/ijms21197304 |
Ejemplares similares
-
Interferon-γ increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer
por: Korentzelos, Dimitrios, et al.
Publicado: (2022) -
Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic Landscape
por: Hall, Mary E, et al.
Publicado: (2020) -
Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches
por: Raheem, Farah, et al.
Publicado: (2023) -
Current Therapeutic Strategies for Metastatic Triple-Negative Breast Cancer: From Pharmacists’ Perspective
por: Li, Shuanghe, et al.
Publicado: (2022) -
Cancer-Associated Fibroblast: Role in Prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance
por: Bedeschi, Martina, et al.
Publicado: (2023)